ArticleWorld journal of hepatology2017

Efficacy and safety of sofosbuvir and ledipasvir in Japanese patients aged 75 years or over with hepatitis C genotype 1.

Yoshinori Ozono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.